Published on
01:44 GMT
FDA animal testing phaseout urges AI-based trial alternatives, organoids, other “NAMs”
The U.S. Food and Drug Administration (FDA) recently announced it plans to phase out animal testing in the development of monoclonal antibody therapies and other drugs and biological products “with more effective, human-relevant methods.” Although fully …
Source:
JD Supra - California
-
Neutral
